Literature DB >> 30653976

Macrophage-secreted TSLP and MMP9 promote bleomycin-induced pulmonary fibrosis.

Guanqun Li1, Fuquan Jin1, Jiangxia Du1, Qiaojun He1, Bo Yang1, Peihua Luo2.   

Abstract

Idiopathic pulmonary fibrosis is a pathological result of dysfunctional repair response to tissue injury, leading to chronically impaired gas exchange and death. Macrophages are believed to be critical in this disease pathogenesis; However, the exact mechanisms remain enigmatic. Here, we demonstrated that macrophages might contribute to pulmonary fibrosis at the early stage because the aggregation of macrophages appeared earlier than epithelial-mesenchymal transition and fibrosis in mouse and rat experimental models of pulmonary fibrosis. It has been found that macrophages could promote epithelial-mesenchymal transition of alveolar epithelial cells and fibroblast migration in co-culture models between macrophages and alveolar epithelial cells/fibroblasts. Importantly, we used protein micro array to analyze the cytokines that were altered after bleomycin treatment. Only thymic stromal lymphopoietin and matrix metalloproteinase 9 were significantly increased. We further confirmed that TSLP participated in the macrophage-induced epithelial-mesenchymal transition of alveolar epithelial cells using a TSLP recombinant protein. MMP9 was also involved in macrophage-induced fibroblast migration, which can be reversed by an inhibitor of MMP9. Collectively, these findings explained the underlying mechanisms of macrophage-promoted pulmonary fibrosis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epithelial-mesenchymal transition; Fibroblast migration; MMP9; Macrophage; Pulmonary fibrosis; TSLP

Mesh:

Substances:

Year:  2019        PMID: 30653976     DOI: 10.1016/j.taap.2019.01.011

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  13 in total

1.  Intrauterine growth restriction induces skin inflammation, increases TSLP and impairs epidermal barrier function.

Authors:  Laura Polányi; Carien M Niessen; Christina Vohlen; Julia Stinn; Tobias Kretschmer; Vanessa Jentgen; Dharmesh Hirani; Silke V Koningsbruggen-Rietschel; Jörg Dötsch; Miguel A Alejandre Alcazar
Journal:  J Mol Med (Berl)       Date:  2020-01-07       Impact factor: 4.599

Review 2.  Recent Advances in Molecular Diagnosis of Pulmonary Fibrosis for Precision Medicine.

Authors:  Mi Ho Jeong; Hongwei Han; David Lagares; Hyungsoon Im
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-20

3.  Proteomic characterization of four subtypes of M2 macrophages derived from human THP-1 cells.

Authors:  Pengfei Li; Chen Ma; Jing Li; Shanshan You; Liuyi Dang; Jingyu Wu; Zhifang Hao; Jun Li; Yuan Zhi; Lin Chen; Shisheng Sun
Journal:  J Zhejiang Univ Sci B       Date:  2022-05-15       Impact factor: 5.552

4.  Airspace Macrophages and Monocytes Exist in Transcriptionally Distinct Subsets in Healthy Adults.

Authors:  Kara J Mould; Camille M Moore; Shannon A McManus; Alexandra L McCubbrey; Jazalle D McClendon; Christine L Griesmer; Peter M Henson; William J Janssen
Journal:  Am J Respir Crit Care Med       Date:  2021-04-15       Impact factor: 21.405

5.  Platelets and Regulatory T Cells May Induce a Type 2 Immunity That Is Conducive to the Progression and Fibrogenesis of Endometriosis.

Authors:  Fengyi Xiao; Xishi Liu; Sun-Wei Guo
Journal:  Front Immunol       Date:  2020-12-14       Impact factor: 7.561

6.  Role of nuclear factor-kappa B in bleomycin induced pulmonary fibrosis and the probable alleviating role of ginsenoside: histological, immunohistochemical, and biochemical study.

Authors:  Dalia Refaat El-Bassouny; Nesreen Mostafa Omar; Hanaa Attia Khalaf; Reem Ahmad Abd Al-Salam
Journal:  Anat Cell Biol       Date:  2021-12-31

Review 7.  Role of macrophages in tumor progression and therapy (Review).

Authors:  Yiwei Xu; Xiaomin Wang; Lijuan Liu; Jia Wang; Jibiao Wu; Changgang Sun
Journal:  Int J Oncol       Date:  2022-04-01       Impact factor: 5.650

8.  Asiaticoside might attenuate bleomycin-induced pulmonary fibrosis by activating cAMP and Rap1 signalling pathway assisted by A2AR.

Authors:  Jing Luo; Ting Zhang; Chengwei Zhu; Junwei Sun; Wenjing Zhu; Wenxiu Ai; Xiaoying Huang; Xiaobing Wang
Journal:  J Cell Mol Med       Date:  2020-06-16       Impact factor: 5.310

Review 9.  The Epithelial-Immune Crosstalk in Pulmonary Fibrosis.

Authors:  Thomas Planté-Bordeneuve; Charles Pilette; Antoine Froidure
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

Review 10.  Adverse immunological responses against non-viral nanoparticle (NP) delivery systems in the lung.

Authors:  Leonor de Braganca; G John Ferguson; Jose Luis Santos; Jeremy P Derrick
Journal:  J Immunotoxicol       Date:  2021-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.